Home > 暂无记录 暂无记录 Signal Pathway

Signal Pathway


In some cases, receptor activation caused by ligand binding to a receptor is directly coupled to the cell's response to the ligand. For example, the neurotransmitter GABA can activate a cell surface receptor that is part of an ion channel. GABA binding to a GABAA receptor on a neuron opens a chloride-selective ion channel that is part of the receptor. GABAA receptor activation allows negatively charged chloride ions to move into the neuron, which inhibits the ability of the neuron to produce action potentials.

  • Pazopanib EY0458

    Pazopanib, an orally available multi-kinase inhibitor of VEGFR, PDGFR, KIT, FGFR, as well as RAF, shows potent activity against a variety of solid tumors. Pazopanib是多重靶点抑制剂，对VEGFR1， VEGFR2，VEGFR3，PDGFR，FGFR，c-Kit 和 c-Fms的IC50分别为10 nM，30 nM，47 nM，84 nM，74 nM，140 nM和146 nM。

    More

  • Doramapimod EY0421

    Doramapimod (BIRB 796)是高度选择性p38α MAPK抑制剂，Kd为0.1 nM，对JNK2，c-RAF，Fyn，Lck，ERK-1，SYK，IKK2，ZAP-70，EGFR，HER2，PKA，PKC和PKCα/β/γ的抑制性较弱。

    More

  • T0070907 EY0423

    T0070907 (T007), a potent and selective PPARγ inhibitor, can reduce α and β tubulin proteins in some cancer cell lines. T0070907是一种选择性的PPARγ抑制剂，IC50为1 nM，比作用于PPARα和PPARδ选择性高800倍以上。

    More

  • Ponatinib EY0427

    Ponatinib (AP24534)是一种新型有效的作用于Abl， PDGFRα， VEGFR2， FGFR1和Src的多靶点抑制剂， IC50分别为0.37 nM， 1.1 nM， 1.5 nM， 2.2 nM和5.4 nM。

    More

  • Fluvastatin Sodium EY0440

    Fluvastatin sodium (XU62-320) is a potent, water-soluble inhibitor of HMG-CoA reductase, widely used as a cholesterol- lowering drug. Fluvastatin sodium 是HMG-CoA还原酶竞争性抑制剂。

    More
    • Current page287, Total Pages360, Total Record1798 First Prev 285286287288289 Next Last Goto
More